In vivo and in vitro antiviral activity of five Tibetan medicinal plant extracts against herpes simplex virus type 2 infection

Pharmaceutical Biology

Volumn 47, Issue 7, 2009, Pages 598-607

  Zhang, Chun Jiang ^a   Li, Wei ^b   Li, Hong Yu ^a   Wang, Yu Ling ^b   Yun, Tian ^a   Song, Zheng Peng ^c   Song, Yan ^b   Zhao, Xing Wen ^b  

^a LANZHOU UNIVERSITY   (China)

^b LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS   (China)

^c NONE

Author keywords

Antiviral activity; Herpes simplex virus; Plaque reduction assays; Real time PCR; Tibetan medicinal plant

Indexed keywords

ACICLOVIR; ACONITUM TANGUTICUM EXTRACT; ANTIVIRUS AGENT; DRACOCEPHALUM HETEROPHYLLUM EXTRACT; DRACOCEPHALUM TANGUTICUM EXTRACT; LAGOTIS BREVITUBA EXTRACT; PLANT EXTRACT; SWERTIA MUSSOTII EXTRACT; UNCLASSIFIED DRUG; VIRUS DNA;

ACUTE TOXICITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA REPLICATION; DNA SYNTHESIS; DRACOCEPHALUM HETEROPHYLLUM; DRACOCEPHALUM TANGUTICUM; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 2; IN VITRO STUDY; IN VIVO STUDY; LAGOTIS BREVITUBA; LD 50; LOW DRUG DOSE; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; SURVIVAL TIME; SWERTIA MUSSOTII; TIBETAN MEDICINE; VIRUS CELL INTERACTION; VIRUS PLAQUE;

DRACOCEPHALUM; GENTIANACEAE; HERPES; HETEROPHYLLUM; HUMAN HERPESVIRUS 2; LAGOTIS; LAMIACEAE; MUS; SCROPHULARIACEAE; SIMPLEXVIRUS; SWERTIA;

EID: 77149124003     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200902905904     Document Type: Article

References (37)

1. Anon (1991): Tibetan Medicine Glossary. Xining, Qinghai People's Press, pp.131-138; 276-289; 384-390; 567-574; 828-932.
2. Anon (1996): Chinese Tibetan Medicine. Shanghai, Science and Technology Press of Shanghai, pp. 351-362; 445-450; 634-640; 780-785; 892-898.
3. Baringer RJ, Swoveland P (1973): Recovery of herpes-simplex virus from human trigeminal ganglions. New Engl Med 288: 648-650.
4. Bean B (1992): Antiviral therapy: Current concept and practices. Clin Microbiol Rev 5: 14-182.
5. Carlucci MJ, Ciancia M, Matulewicz MC, Cerezo AS, Damonte EB (1999): Antiherpetic activity and mode of action of natural carrageenans of diverse structural types. Antivir Res 43: 93-102.
6. Cassady KA, Whitley RJ (1997): New therapeutic approaches to the alphaherpesvirus infections. J Antimicrob Chemother 39: 119-128.
7. Celum CL (2004). The interaction between herpes simplex virus and human immunodeficiency virus. Herpes 11(Suppl 1): 36A-45A.
8. Cheng HY, Lin TC, Yang CM, Wang KC, Lin LT, Lin CC (2004): Putranjivain A from Euphorbia jolkini inhibits both virus entry and late stage of herpes simplex virus type 2 infection in vitro. J Antimicrob Chemother 53: 577-583.
9. Chiang LC, Chiang W, Chang MY, Ng LT (2002): Antiviral activity of Plantago major extracts and related compounds in vitro. Antivir Res 55: 53-62.
10. Englund JA, Zimmerman MK, Swierkosz EM, Goodman JL, Scholl DR, Balfour HH (1990): Herpes simplex virus resistant to acyclovir. Arch Inter Med 112: 416-422.
11. Erlich KS, Mills J, Chatis P, Mertz GJ, Busch DF. Follansbee SE, Grant RM, Crumpacker CS (1989): Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. New Engl Med 320: 293-296.
12. Gong E, Matthews B, McCarthy T, Chua JH (2005): Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses. Antivir Res 68: 139-146.
13. Hai P, Zhou S, Shang H, Zhao G (1997): Antianoxic effects of Dracocephalum tanguticum on brain of mice. Zhong Yao Cai 20: 198-200.
14. 4. J Med Pharm China Minorities 5: 20-21.
15. Hook EW, Cannon RO, Nahmias AJ (1992): Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J Infect Dis 165: 251-255.
16. Jin L, Chen Z (2006): Anticancer research of Lagotis Brevituba Maxim. J Qinghai Normal University (Natural Science) 2: 86-87.
17. Kuo YC, Chen CC, Tsai WJ, Ho YH (2001): Regulation of herpes simplex virus type 1 replication in Vero cells by Psychotria serpens: Relationship to gene expression, DNA replication, and protein synthesis. Antivir Res 51: 95-109.
18. Lapucci A, Macchia M, Parkin A (1993): Antiherpes virus agents: A review. Farmaco, IL. 245-260
19. Li SY, Chen C, Zhang HQ, Guo HY, Wang H (2005): Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antivir Res 67: 18-23.
20. Lorke D (1983): A new approach to practical acute toxicity testing. Arch Toxicol 54: 275-287.
21. Lu M, Tian X (1999): Analysis of essential oil of Dracocephalum heterophyllum. Acta Pharma Sini. 34: 925-927.
22. Luo DS (1997): Zhonghua Tibetan Herbal. Beijing, National Press, pp. 445-448.
23. McGowan I (2006): Microbicides: A new frontier in HIV prevention. Biologicals 34: 241-255.
24. Nugier F, Collins JN, Langlois M (1992): Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: Report on a two-year sensitivity screening survey. J Med Virol 36: 1-12.
25. Mbopi-Keou, FX, Gresenguet, Mayaud P, Weiss, HA, Gopal R, Matta M, Paul, JL, Brown DWG, Hayes RJ, Mabey DCW, Belec L (2000): Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women. J Infect Dis 182: 1090-1096.
26. Mosmann T (1983): Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 65: 55-63.
27. Rajcani J, Vojvodova A (1998): The role of herpes simplex virus glyco-proteins in the virus replication cycle. Acta Virol 42: 103-118.
28. Shi GY, Lu RH (2003): Study on chemical constituents of essential oil from Lagotis brevituba. Nat Prod Res Dev 15: 23-28.
29. Spear PG, Shieh MT, Herold BC, WuDunn D, Koshy TI (1992): Heparan sulfate glycosaminoglycans as primary cell surface receptors for herpes simplex virus. Adv Exp Med Biol 313: 341-353.
30. Schacker T (2001): The role of HSV in the transmission and progression of HIV. Herpes 8: 46-49.
31. Sambrook J, Fritsch EF, Maniatis T (1989): Molecular Cloning: A Laboratory Manual. New York, Cold Spring Harbor Laboratory, pp. 851-862.
32. Thi TN, Deback C, Malet I, Bonnafous P, Agut H (2006): Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR. Antivir Res 69: 152-157.
33. Whitley RJ, Kimberlin DW, Roizman B (1998): Herpes simplex viruses. Cli Infect Dis 26: 97-109.
34. Xue D, Yang F, Bee D (1994): Modification of the rabbit carotid body type I cell mitochondria by high altitude exposure and the effects of Dracocephalum heterophyllum. Adv Exp Med Biol 360: 357-360.
35. Wang YB, Huang R, Zhang HB (2005): Diterpenoid alkaloid from Aconitum tanguticum. Helve Chimi Acta 88: 1081-1084.
36. Yang CM, Cheng HY, Lin TC, Chiang LC, Lin CC (2005): Acetone, ethanol and methanol extracts of Phyllanthus urinaria inhibit HSV-2 infection in vitro. Antivir Res 67: 24-30.
37. Zhang XF, Hu BL, Wang SX (1994): The chemical constituents from Dracocephalum tanguticum Maxim. Acta Bot Sini 36: 645-648.